Abstract
The best treatment for chemotherapy-induced nausea and vomiting (CINV) is prevention. The regimen used for prevention needs to cover both acute and delayed CINV and will vary depending on the emetogenic potential of the chemotherapy regimen being used. Improved understanding of the pathophysiology of this adverse effect has lead to the development of new agents which better target the underlying pathology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 25-29 |
| Number of pages | 5 |
| Journal | Journal of Managed Care Medicine |
| Volume | 15 |
| Issue number | 1 |
| State | Published - 2012 |
ASJC Scopus subject areas
- Health Policy